Search

everythinglearnresearchcommunity

for

Search:↓

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Skin issues can indicate immune system problems.

Hair loss caused by genetics and hormones; more research needed for treatments.

Finasteride and dutasteride increase sexual dysfunction reports.

Higher RBP4 levels found in people with two types of hair loss.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Dupilumab can cause rare side effects like a rash on the face and neck.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Melanocytes from human fetal hair follicles were successfully cultured, showing potential for hair disease research and clinical use.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Polyamines are abundant in certain parts of rat hair follicles and may play a key role in hair growth.

The study found markers indicating that cells responsible for hair color are differentiating in specific areas of the hair follicle.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.

Understanding hair follicle development can help treat hair loss, skin regeneration, and certain skin cancers.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Topical oligonucleotide therapy targets hair follicles effectively.

Benign follicular mucinosis involves immune cells attacking hair follicles.